Medicare (Traditional Part A & B) · spinal cord stimulation
v1verified 2026-07-24
✓ conditional · medicare ncd
Criteria checklist
0 of 7 tickedIndications
- enumerated: no
- description: chronic intractable pain; best suited to neuropathic pain
Conservative care
- required: yes
- satisfied by:
- tried and unsatisfactory
- judged unsuitable or contraindicated
- modalities named:
- pharmacologic
- surgical
- physical
- psychological
- min duration months: not stated in the policy
Trial
- required: yes
- min duration days: not stated in the policy
- success criteria:
- logic: (pain_reduction OR med_reduction) AND functional_improvement
- pain reduction pct: 50
- med reduction pct: 50
- functional improvement: required
- threshold is binding: no
Psychological evaluation
- required: yes
- must clear: yes
- note posture: ordered at trial; pending; patient referred; result routed to authorization
Screening
- multidisciplinary team: required
- late or last resort: yes
Quantity limits
- applies: no
Device / waveformagnostic
Payor-specific notes
Governed by NCD 160.7, not an LCD. The universally-expected documentation standard (>=50% pain or analgesic reduction + functional gain) derives from the Noridian/Palmetto LCDs and should still be documented though not formally binding here. Trial is the hurdle: once a trial is approved and successful, implant approval follows and is templated separately.
Ticks are a documentation aid — nothing is stored; they reset on reload.
Dot phrase
Lean narrative A&P attestation. `***` = fill-in. Every clinical assertion maps to an NCD 160.7 condition.
.SCSTRIALMCARE
.SCSTRIALMCARE Assessment: *** — chronic intractable pain, predominantly neuropathic, involving the ___ region, present *** and refractory to treatment. Medical necessity per Medicare NCD 160.7 (Electrical Nerve Stimulators): this patient has been managed with pharmacologic therapy, physical therapy, and interventional treatment including ESI / nerve blocks where appropriate — *** — with unsatisfactory response, or these measures were contraindicated. Spinal cord stimulation is pursued as a late-resort therapy. Multidisciplinary screening is complete; psychological evaluation was ordered at the time of trial, the patient has been referred, and the result is pending and will be forwarded to authorization. History, imaging, and screening documentation are on file. Plan: Percutaneous SCS trial. Trial response — targeting >=50% reduction in target pain and/or >=50% reduction in analgesic use with functional improvement — will be assessed and documented to support permanent implantation. Risks, benefits, and alternatives discussed; consent obtained.
Where this payor diverges from the Medicare baseline
Cautions
Prior-auth pathway
- required: yes
- pathway: OPD prior auth list (hospital outpatient)
Provenance
- authority:
- type: ncd
- id: 160.7
- title: Electrical Nerve Stimulators
- applies because: WPS and CGS publish no SCS LCD; both defer to NCD 160.7
- excluded:
- L35136
- L36204
- L37632
- source: https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?ncdid=240
- effective: 1995-08-07 · payor last reviewed: 2023-08-17 · we verified: 2026-07-24 · v1
Change history
- 2026-07-24scs/medicare: verified vs NCD 160.7 text (MCP) - criteria+dates match, no change; last_verified 2026-07-24
4c2b316c7b - 2026-06-27Seed: locked schema + SCS templated for Medicare (NCD 160.7) and Aetna (CPB 0194)
89cec9dbfe